Italian risk-sharing agreements on drugs: are they worthwhile?

被引:0
|
作者
Livio Garattini
Alessandro Curto
Katelijne van de Vooren
机构
[1] IRCCS Institute for Pharmacological Research ‘Mario Negri’,CESAV, Centre for Health Economics
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1 / 3
页数:2
相关论文
共 50 条
  • [1] Italian risk-sharing agreements on drugs: are they worthwhile?
    Garattini, Livio
    Curto, Alessandro
    van de Vooren, Katelijne
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2015, 16 (01): : 1 - 3
  • [2] Pharmaceutical Risk-Sharing Agreements
    Afschin Gandjour
    PharmacoEconomics, 2009, 27 : 431 - 432
  • [3] Pharmaceutical Risk-Sharing Agreements
    Joseph P. Cook
    John A. Vernon
    Richard Manning
    PharmacoEconomics, 2008, 26 : 551 - 556
  • [4] Pharmaceutical risk-sharing agreements
    Cook, Joseph P.
    Vernon, John A.
    Manning, Richard
    PHARMACOECONOMICS, 2008, 26 (07) : 551 - 556
  • [5] Pharmaceutical Risk-Sharing Agreements
    Gandjour, Afschin
    PHARMACOECONOMICS, 2009, 27 (05) : 431 - 432
  • [6] POTENTIAL RISK-SHARING AGREEMENTS FOR VACCINES
    Terlinden, A.
    Ethgen, O.
    Demarteau, N.
    Curran, D.
    VALUE IN HEALTH, 2014, 17 (07) : A669 - A670
  • [7] Risk-sharing agreements, present and future
    Goncalves, Francisco R.
    Santos, Susana
    Silva, Catarina
    Sousa, Gabriela
    ECANCERMEDICALSCIENCE, 2018, 12
  • [8] Where Are We on "Risk-Sharing" Agreements?
    Neumann, Peter J.
    VALUE IN HEALTH, 2013, 16 (05) : 701 - 702
  • [9] Insurance-based risk-sharing agreements
    Augustin Terlinden
    Amine Aissaoui
    Olivier Ethgen
    Journal of Pharmaceutical Policy and Practice, 8 (Suppl 1)
  • [10] Pool size and the sustainability of optimal risk-sharing agreements
    Barigozzi, Francesca
    Bourles, Renaud
    Henriet, Dominique
    Pignataro, Giuseppe
    THEORY AND DECISION, 2017, 82 (02) : 273 - 303